Today's Healthcare Pulse
Allogene Therapeutics CEO David Chang to step down
Allogene Therapeutics announced that chief executive David Chang will leave his role. The news was reported by STAT+ and echoed in a follow‑up piece covering broader pharma updates.
Also developing:
By the numbers: Boston Scientific invests $1.5B for 34% stake in MiRus
How One Health System Attained a Patient Safety Milestone: Zero CAUTI Infections
North Country Healthcare, an alliance of three critical‑access hospitals in New Hampshire, launched the staff‑driven "Lines and Drains" project using its Meditech Expanse EHR to standardize catheter documentation and create real‑time performance dashboards. By redesigning workflows, linking orders to worklists, and embedding daily accountability, the system achieved 100% documentation compliance and eliminated catheter‑associated urinary tract infections (CAUTI) for over eight months. Reporting effort dropped from 50 hours to under four hours per month, while barcode medication scanning compliance reached 99.5% in 2025.
NewCo Boom Shows No Signs of Slowing
The NewCo model, where Asian biotech assets are spun out into Western start‑ups backed by Western capital, surged in 2025 with 13 new companies—more than double the six disclosed in 2024. Early 2026 already sees three additional launches, including Kidswell...
VCU Health on Hospital-at-Home and RPM Governance
VCU Health, Virginia’s first hospital‑at‑home (HaH) provider, is showcasing its digital‑health journey at HIMSS 2026. Director David Collins will detail how lessons from the adult HaH and remote patient monitoring (RPM) programs shaped a governance framework for a new NICU RPM...
Frist Cressey Ventures Raises $425M Fund to Invest in AI-Native Care
Frist Cressey Ventures closed an oversubscribed $425 million Fund IV, lifting its assets under management close to $1 billion. The new fund zeroes in on early‑stage, AI‑native healthcare companies that can reshape care delivery. Strategic limited partners such as Cigna, MedStar Health and...
Protecting a Healthcare Facility From All Angles
Parkland Center for Clinical Innovation is piloting an AI‑driven predictive tool that scores inpatient threat levels using EHR data, social determinants and real‑time updates, alerting clinicians through the electronic health record. The system gives staff early awareness of potentially violent...
FDA to Review Moderna’s Flu Jab on Agency Pivot
The FDA has reversed its earlier refusal and will now evaluate Moderna’s mRNA‑1010 seasonal flu vaccine using a two‑track approach: a full Biologics License Application review for adults 50‑64 and an accelerated approval pathway for those 65 and older, contingent...
Aceclidine
Aceclidine (Vizz®) received FDA approval in 2025 as an ophthalmic solution for presbyopia, targeting age‑related near‑vision loss. The drug acts as a pupil‑selective muscarinic agonist, inducing miosis without significant ciliary muscle activity, thereby enhancing depth of focus through a pinhole...
Medline Addresses Bed Fire Risk Linked to Death
Medline is revising usage instructions for its home‑care adjustable beds after the FDA documented safety incidents involving hand‑control pendants that sparked, melted or ignited, and entrapment hazards from third‑party accessories. The agency recorded 12 injuries and two deaths—one fire‑related and...
Registered Outsourcing Facilities
The FDA’s updated list of Section 503B outsourcing facilities details registration dates, annual fee requirements, and inspection status as of February 18, 2026. Facilities must complete initial registration and then re‑register each year between October 1 and December 31, otherwise they are delisted on January 1....
Global Conference to Tackle Longevity Clinical Translation
The National University of Singapore Academy for Healthy Longevity is hosting the Geromedicine Conference on February 26-27, 2026, bringing together geroscience researchers, clinicians, and industry leaders. The event emphasizes clinical translation of molecules such as NAD+ precursors, urolithin A, and ergothioneine,...
Identy Joins Africa’s Push for Digital Identity in Humanitarian Healthcare
Identy is partnering with the volunteer NGO HumanCoop to roll out offline facial‑recognition tools for undocumented patients in northern Mauritania, creating portable digital medical IDs that work without internet. The initiative will initially cover the Bir Mogrein community of over 2,500...
Lilly to Pay CSL $100M to License Monoclonal Antibody Targeting IL-6
Eli Lilly has agreed to pay CSL Ltd. $100 million to license the monoclonal antibody clazakizumab, which targets interleukin‑6. Under the agreement, CSL will keep development rights for the drug’s use in preventing cardiovascular complications in end‑stage kidney disease patients, currently...
From DNA To Decision
Rapid functional testing is turning ambiguous genetic variants into actionable medical decisions. A zebrafish model proved a newborn‑identified SMN1 mutation benign, allowing clinicians to defer costly SMA therapy. This proof‑of‑concept shows whole‑genome sequencing can move from data to diagnosis within...
Health Fraud Scams
The FDA has escalated its enforcement against health‑fraud scams, targeting products ranging from 7‑OH opioid derivatives and tianeptine‑laden supplements to adulterated honey and toxic cosmetics. Recent public notifications and warning letters detail seizures, recalls, and advisories aimed at protecting consumers...
Pharmaceutical Quality Resources
The FDA’s Center for Drug Evaluation and Research created the Office of Pharmaceutical Quality (OPQ) to standardize drug quality oversight across all manufacturing sites, both domestic and foreign. OPQ’s mandate spans new drugs, biologics, generics, biosimilars, over‑the‑counter products, and certain...
FDA Accepts BMS Protein Degrader for Review; Disc Rare Disease Drug Rejected
The FDA has accepted Bristol Myers Squibb’s protein‑degrading multiple myeloma candidate iberdomide for review, with a decision expected by Aug. 17 after a Phase 3 trial showed higher minimal residual disease‑negative rates. In contrast, the agency rejected Disc Medicine’s accelerated‑approval bid for...
Ambient AI in the Exam Room: For Better Care and Better Caring
Leonard Calabrese argues that ambient artificial intelligence—low‑cost, always‑on tools integrated into the exam room—can free clinicians from the constant EMR distraction and restore genuine face‑to‑face interaction. By handling routine documentation and patient‑message drafting, AI lets physicians focus on non‑verbal cues...
Digital Path Practices Reflected in Latest Checklist Changes
The College of American Pathologists issued the 2025 accreditation checklist on Dec. 9, adding a new “Digital Pathology Including Remote Data Assessment” section. The revision requires laboratories to validate digital pathology systems, document remote review locations, and treat remote CLIA‑certified sites...
Social Meals, Sustainable Diets,
This week on Lifers, Dr. Zeke Emanuel thinks you can eat the ice cream. Timestamps: (00:00) Preview (00:59) Intro (02:25) The inspiration behind the book (04:20) The importance of socialization and shared meals (07:33) Sustainability versus the short-term hustle (08:30) The truth about supplements and regulation (12:04) Sponsor:...
AI in Healthcare Starts Long Before the Exam Room
AI-driven clinical tools are rapidly improving diagnosis and treatment, but they leave patients exposed to hidden financial risks. A case of an autonomous AI ER physician resulted in a $37,000 out‑of‑network bill, highlighting systemic navigation failures. While clinical AI promises...
Deploying AI 'Allows Doctors to Be Doctors' Again
Innovaccer released the whitepaper "Autonomous Healthcare" outlining AI’s role in alleviating clinicians’ administrative load. The report highlights AI‑powered documentation, scheduling, and data integration tools that can reclaim up to 30% of physicians’ time. CEO Abhinav Shashank argues that these efficiencies...
Rox Heart Radio: Why AI?
Rox Heart Radio released a new episode titled “Why AI?” featuring host Roxana Mehran in conversation with cardiology researchers Ami Bhatt and Rohan Khera. The trio explores how artificial intelligence is poised to reshape cardiovascular care, from imaging interpretation to risk prediction....
Addressing the 58% Launch Failure Rate: Accelerating Market Access Through Intelligent Decision-Making
Pharma launches are missing the mark 58% of the time, a failure rate driven by poor market insight and fragmented decision‑making. Accelerating market‑access planning from pre‑Phase 2 and integrating real‑world data can give companies a strategic north star. Purpose‑built AI tools...
Rural Emergency Medicine in New Mexico: A Physician’s Firsthand Account
Sarah Bridge, an emergency physician, recounts four years of frontline care in rural New Mexico’s Indian Health Service facilities, where chronic ICU bed shortages, equipment failures and staffing cuts force dangerous patient transfers and improvised treatments. She highlights how historical...
Innovation in Ophthalmology: How Biotechs Are Reshaping the Treatment of Eye Diseases
Vision loss remains a leading disability, prompting biotech firms to shift from symptom‑management to disease‑modifying therapies. Gene‑replacement approaches using AAV vectors dominate the inherited retinal disease pipeline, highlighted by Luxturna’s success and multiple late‑stage candidates such as Beacon’s laru‑zova and...
Video Wednesday
On November 20, 2020, Verb and Johnson & Johnson unveiled OTTAVA, a six‑armed robotic platform designed for minimally invasive surgery. The system integrates AI‑driven vision, haptic feedback, and modular tooling to automate complex suturing and tissue manipulation. Early trials report a 30%...
Livi Partners with CloudFit to Bridge Healthcare and Holistic Wellbeing Through AI-Powered Preventative Health Platform
Livi, Europe’s leading digital‑first healthcare provider, has partnered with AI‑driven holistic platform CloudFit to launch an integrated preventative health solution. The collaboration lets Livi GPs refer patients to CloudFit’s fitness, nutrition and lifestyle coaching, creating a continuous care loop between...
The Murky Waters of Healthcare Cost Transparency: What Plan Sponsors Can Control
The 2021 Consolidated Appropriations Act introduced mandatory broker compensation disclosures and broader pricing data for health plans, pushing plan sponsors to adopt fiduciary rigor similar to retirement plans. Yet, translating transparency into cost control remains difficult as procedure prices can...
Lab Reins in Magnesium Tests with Decision Support
Washington University in St. Louis deployed a clinical decision‑support workflow to curb over‑ordering of inpatient magnesium tests, a high‑volume assay often ordered by default on daily order sets. Analysis of Epic data showed half of the orders were routine "AM...
A New Era For Blindness Treatment Is Within Sight
A wave of clinical trials is testing stem‑cell, gene‑editing and bionic‑eye technologies to treat blindness, especially retinitis pigmentosa and dry age‑related macular degeneration. Early‑stage studies from UC Davis, BlueRock Therapeutics and the University of Michigan report measurable vision gains, such as...
Broker’s Call: Ipca Laboratories (Buy)
Ipca Laboratories posted a robust 19% year‑on‑year EBITDA increase to ₹530 crore, surpassing broker estimates, while revenue rose 6.6% to ₹2,400 crore. Domestic formulation sales grew 12% and export formulation climbed 17%, offset by flat API sales overall but a 26% rebound...
Trauma Reactivation: Why News Headlines Trigger Past Abuse
Recent high‑profile sexual‑abuse scandals, such as the Jeffrey Epstein case, are prompting a wave of trauma reactivation among survivors who had previously kept their experiences hidden. Patients often present with insomnia, irritability, increased alcohol use, or vague anxiety that they...
Making Global Market Access Practical – How Medilink North of England Supports International Growth
Medilink North of England provides a structured market‑access offering that helps MedTech and digital‑health innovators move beyond regulatory clearance to achieve commercial adoption in overseas health systems. The service is built around five pillars—market segmentation, global strategy, regulatory documentation, reimbursement...
Global Genomics: Representative Research Is Key to Unlocking the Full Potential of Precision Medicine
Professor Segun Fatumo highlights the stark under‑representation of African genomes in global research, where over 86% of GWAS participants are of European ancestry despite Africa housing the greatest genetic diversity. He explains how this gap limits the accuracy of polygenic...
Overloaded with Patient Records? How MVSPlus Keeps You Organized
Healthcare providers are drowning in ever‑growing patient records, leading to missed follow‑ups, delayed appointments, and staff burnout. MVSPlus offers a dedicated virtual assistant that cleans, updates, and organizes charts in real time, integrating seamlessly with existing workflows. By handling routine...
IRF7 Expression Drives Instability in Atherosclerotic Plaques
Researchers identified interferon regulatory factor 7 (IRF7) as a master transcriptional driver that pushes vascular smooth muscle cells (SMCs) into a pro‑inflammatory, macrophage‑like state, a key step in plaque destabilisation. Single‑cell RNA sequencing and trajectory analysis uncovered an intermediate stem‑endothelial‑monocyte...
Novartis' Oral BTK Drug Moves the Needle in CINDU
Novartis announced that its oral BTK inhibitor Rhapsido (remibrutinib) achieved significantly higher complete response rates than placebo in the phase 3 RemIND trial for the three most common forms of chronic inducible urticaria (CINDU). The drug, already approved for chronic spontaneous...
AI Transforms Unknown Genetic Variants Into Actionable Insights
A “Variant of Unknown Significance” is a genetic finding that can’t yet be interpreted, leaving families with uncertainty instead of answers. Now, AI agents can help connect sequencing data with scientific literature and biological context to turn VUS into traceable, evidence-backed...
FDA Chief: Most Drugs Belong Over‑the‑counter
FDA chief Marty Makary says 'everything should be over the counter' unless drug is unsafe or addictive https://t.co/HiYBuxvyWC
Federal Vaccine Panel Meeting Delayed After HHS Missed Deadlines
Upcoming meeting of federal vaccine panel may be postponed after HHS missed deadlines https://t.co/zfAl7owoQg via @statnews
MRNA Vaccines Advance Triple‑negative Breast Cancer Therapy
The unfounded move by @HHSGov against mRNA vaccines will hurt our future potent immune therapy vs cancer. Another point of progress for triple-negative breast cancer with individualized neoantigen mRNA vaccines today @Nature Adds to successful pancreatic, renal cell, melanoma reports...
Listen to Biology’s Early Whispers to Prevent Disease
We could prevent diseases so much better but we haven't learned to listen to when biology whispers long (10 + years) in advance. A key theme in Super Agers, too. https://t.co/0pSap3f32N @NathanPriceSci @ @nrappapo @BuckInstitute example below for Type 2...
Agentic AI Enables Accurate Rare Disease Diagnosis via DeepRare
Another good use case for agentic AI in medicine: diagnosis of rare diseases. Exemplified by DeepRare https://t.co/XBd68V3iDl https://t.co/rBl5yn95sI
ECM: Scalable Solution to Legacy Data Risks
Legacy systems are piling up—and so is the risk. Great insights from @QuestDX on why ECM is the smartest, most scalable way to archive and protect healthcare data. ➡️ https://t.co/NcgrjGUq3D #HealthECM #HealthIT #HITSM
Pharma Demands FDA Stability as Leadership Sparks Drama
The pharmaceutical industry needs stability & clear guidance from #FDA as it attempts to bring through licensure new drugs & vaccines. Vinay Prasad, FDA's head of biologics, has brought drama to a setting where it's not welcome, @matthewherper.bsky.social writes. https://t.co/Qaw1QmYNpL
Emerging Tech Will Revolutionize Pharma Manufacturing and Distribution
This book explains how disruptive technologies and emerging trends such as robotics, artificial intelligence, 3D printing, precision medicine or patient design will impact the manufacturing and distribution of pharmaceuticals in order to prepare successfully for a better future of healthcare. It's...
FDA's Moderna U‑turn Highlights Agency Chaos
The FDA’s Moderna $MRNA pirouette is one more sign of chaos at the agency https://t.co/zThJqhT2BS via @matthewherper
FDA Relents, Agrees to Review Moderna's mRNA Flu Vaccine
#FDA backs down on #Moderna: The agency had refused to review the company's licensure application for an mRNA flu vaccine, but after significant pushback has relented. https://t.co/omo7bEBQGW
Moderna's Flu Vaccine Review Set for August 5
$MRNA says FDA will now review its flu vaccine. PDUFA date is Aug. 5. https://t.co/npZzeEa5nk
FDA Splits Moderna Flu Vaccine Review by Age
FDA agrees to review Moderna flu vaccine application, splitting review into standard approval for those under 65 and accelerated approval for those 65 and above. $mrna https://t.co/HMMlPm0PGh